Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 12 de 12
Filter
1.
J Clin Microbiol ; 39(12): 4269-73, 2001 Dec.
Article in English | MEDLINE | ID: mdl-11724831

ABSTRACT

Viral load is an important marker of activity of viral diseases for a number of viruses. We wished to evaluate whether the viral load of human herpesvirus 8 (HHV-8) in peripheral blood was a consistent feature of Kaposi's sarcoma (KS) patients and whether the viral load correlated with human immunodeficiency virus (HIV) RNA levels, CD4 counts, and/or the HHV-8 seroreactivity. Fifty-four consecutive plasma samples from 14 patients with KS were evaluated for HHV-8 viral load by quantitative real-time PCR. Samples were analyzed at the start of highly active antiretroviral therapy (HAART) and at different intervals during treatments. The median HHV-8 DNA load before HAART treatment was 8,998 (ranging from 170 to 40,100) copies/ml and 12,270 (ranging from 40 to 142,575) copies/ml during HAART. There were both increasing and decreasing trends. There was an association between HHV-8 DNA and HIV RNA viral loads (odds ratio [OR] = 5.40; 95% confidence interval [95% CI], 1.54 to 18.98) and between HHV-8 viral load and CD4 cell counts (OR = 7.24; 95% CI, 1.30 to 40.35). High HHV-8 viral load was also correlated with the titers of antibodies to the lytic HHV-8 antigen detected with immunofluorescence (P < 0.01), but not with antibodies to the latent HHV-8 antigen. In conclusion, we found that HHV-8 viremia in KS is associated with HIV viral load, CD4 cell counts, and lytic HHV-8 serological reactivity. HHV-8 viral load monitored by real time PCR might be useful for determination HHV-8 viral load during the follow-up of KS patients.


Subject(s)
AIDS-Related Opportunistic Infections/virology , DNA, Viral/blood , HIV Infections/complications , Herpesvirus 8, Human/isolation & purification , Sarcoma, Kaposi/virology , Adult , Antibodies, Viral/blood , Antiretroviral Therapy, Highly Active , CD4 Lymphocyte Count , Female , HIV Infections/drug therapy , HIV Infections/virology , HIV-1/genetics , HIV-1/isolation & purification , HIV-1/physiology , Herpesvirus 8, Human/genetics , Herpesvirus 8, Human/immunology , Herpesvirus 8, Human/physiology , Humans , Male , Middle Aged , Polymerase Chain Reaction/methods , RNA, Viral/blood , Viral Load
2.
Scand J Infect Dis ; 33(9): 648-58, 2001.
Article in English | MEDLINE | ID: mdl-11669221

ABSTRACT

Two diseases that for many years have been suspected to be of viral origin are multiple sclerosis (MS) and Kaposi's sarcoma (KS). With the use of a new technique called representational difference analysis both these diseases have recently been associated with new lymphotropic herpesviruses, i.e. human herpesviruses (HHV) 6 and 8. HHV-6 is a ubiquitous virus and the etiological agent of exanthema subitum. Viral neuroinvasion occurs frequently in primary HHV-6 infection, and meningitis, encephalitis and demyelination have been described as rare complications. A relation with MS has been suggested for HHV-6, as the virus has been detected in MS plaques in the brain. Data from different studies are, however, conflicting and a definitive role for HHV-6 in MS pathogenesis has not been established. HHV-8 is believed to be the causative agent of KS, and is also associated with some rare hematological malignancies. The viral genome contains several potential oncogenes that are believed to have been picked up from the human genome during evolution. The role of HHV-8 in healthy, immunocompetent individuals is however uncertain. In conclusion, the full spectrum of human diseases associated with these new viruses is not yet understood, and rapid developments in molecular biology will continue to shed new light on the interactions between herpesviruses and their hosts.


Subject(s)
Herpesvirus 6, Human/isolation & purification , Herpesvirus 8, Human/isolation & purification , Multiple Sclerosis/virology , Sarcoma, Kaposi/virology , Africa/epidemiology , Chronic Disease , Herpesviridae Infections/virology , Herpesvirus 6, Human/genetics , Herpesvirus 8, Human/genetics , Humans , Italy/epidemiology , Multiple Sclerosis/epidemiology , Sarcoma, Kaposi/epidemiology
3.
APMIS ; 109(6): 401-11, 2001 Jun.
Article in English | MEDLINE | ID: mdl-11506471

ABSTRACT

Multiple sclerosis (MS) is one of the most common disabling neurological diseases affecting young adults. It is a chronic disease characterised by inflammation and demyelination. The aetiology of MS is still unknown, but involvement of viruses has been suspected for many years. Recently much interest has focused on human herpesvirus 6 (HHV-6), since the virus has been detected in MS plaques in the brain and patients with MS have been shown to have an aberrant immune response to HHV-6. Results from different studies are, however, conflicting and in the light of the long list of previous claims to have found the viral aetiology of MS it is necessary to interpret the HHV-6 findings with great caution. Possible mechanisms for virally induced demyelination and autoimmunity are discussed in this review, and the evidence for and against a role for HHV-6 in MS is summarised.


Subject(s)
Herpesvirus 6, Human/pathogenicity , Multiple Sclerosis/etiology , Antigens, CD/metabolism , Epidemiologic Factors , Herpesviridae/pathogenicity , Herpesviridae Infections/complications , Herpesvirus 6, Human/immunology , Herpesvirus 6, Human/isolation & purification , Humans , Measles virus/pathogenicity , Membrane Cofactor Protein , Membrane Glycoproteins/metabolism , Multiple Sclerosis/epidemiology , Multiple Sclerosis/immunology , Multiple Sclerosis/virology , Receptors, Virus/metabolism , Retroviridae/pathogenicity
4.
Sex Transm Dis ; 28(5): 300-6, 2001 May.
Article in English | MEDLINE | ID: mdl-11354271

ABSTRACT

BACKGROUND: Epstein-Barr virus (EBV) and human herpesvirus 8 (HHV-8) are two related herpesviruses that may be sexually transmitted. GOAL: To examine the presence of HHV-8 and EBV DNA in the female genital tract. STUDY DESIGN: Real-time polymerase chain reaction systems for quantification of DNA from HHV-8, EBV, and herpes simplex virus type 2 were developed and used for examination of cervical secretions from 112 Swedish women. HHV-8, EBV, and herpes simplex virus type 2 serology was also performed on samples from all subjects. RESULTS: EBV DNA was found in 10 cervical secretion samples, sometimes in high amounts. No cervical secretion or leukocyte sample contained detectable HHV-8 DNA. Antibodies to HHV-8-latent and -lytic antigens were found in 2.7 % and 24% of serum samples, respectively. CONCLUSION: This study supports a possible sexual route of transmission for EBV but not for HHV-8. The new real-time polymerase chain reaction systems could be valuable in future studies of relations between virus load and disease.


Subject(s)
Epstein-Barr Virus Infections/transmission , Herpesviridae Infections/transmission , Herpesvirus 4, Human/isolation & purification , Herpesvirus 8, Human/isolation & purification , Sexually Transmitted Diseases, Viral/transmission , Adolescent , Adult , Antibodies, Viral/blood , Cervix Uteri/metabolism , Cervix Uteri/virology , DNA, Viral/analysis , Epstein-Barr Virus Infections/blood , Female , Herpesviridae Infections/blood , Herpesvirus 2, Human/genetics , Herpesvirus 2, Human/immunology , Herpesvirus 2, Human/isolation & purification , Herpesvirus 4, Human/genetics , Herpesvirus 4, Human/immunology , Herpesvirus 8, Human/genetics , Herpesvirus 8, Human/immunology , Humans , Middle Aged , Polymerase Chain Reaction , Sexually Transmitted Diseases, Viral/blood
5.
J Med Virol ; 62(4): 498-504, 2000 Dec.
Article in English | MEDLINE | ID: mdl-11074479

ABSTRACT

Human herpesvirus 8 (HHV-8) is a herpesvirus associated with Kaposi's sarcoma (KS). An immunofluorescence assay was used for detection of IgG, IgM, and IgA antibodies against lytic and latent HHV-8 antigens to analyse samples from KS patients (n = 8), healthy blood donors (n = 162), individuals with a high risk sexual behaviour (n = 114), and bone marrow transplant patients (with high risk for bloodborne infections) (n = 34) in Sweden. Of the KS patients, 88% had IgG antibodies to both lytic and latent antigens by immunofluorescence. In all other groups, antilatent antibodies were rare (0-2.6%). IgG antibodies to the lytic antigens were found, by immunofluorescence, in 20% of the blood donors, 31% of the high risk patients, and in 24 and 29% of the bone marrow transplant patients (pre- and post-transplant samples, respectively). For verification of the specificity of the anti-lytic antibodies, 170 of the samples were also tested blindly at different laboratories world-wide with five other assays shown previously to detect HHV-8 antibodies in most KS patients. By using two recombinant HHV-8 proteins (ORF65/vp17 and K8.1/gp 35-37) in ELISA, a whole-virion ELISA and two immunofluorescence assays confirmation of the reactivity against lytic viral antigens was sought. The comparison of the different methods suggested the K8.1 ELISA to be highly specific and also showed a good agreement between two of the immunofluorescence assays. However, generally there was a poor correlation for positive results, indicating the need of further methodological development.


Subject(s)
Antibodies, Viral/blood , Antigens, Viral/immunology , Blood Donors , Bone Marrow Transplantation/adverse effects , Herpesvirus 8, Human/immunology , Sarcoma, Kaposi/immunology , Adolescent , Adult , Aged , Antibodies, Viral/immunology , Bone Marrow Transplantation/immunology , Enzyme-Linked Immunosorbent Assay/methods , Female , Fluorescent Antibody Technique , Humans , Immunoglobulin A/blood , Immunoglobulin A/immunology , Immunoglobulin G/blood , Immunoglobulin G/immunology , Immunoglobulin M/blood , Immunoglobulin M/immunology , Male , Middle Aged , Risk Factors , Risk-Taking , Sarcoma, Kaposi/blood , Sweden , Virion/immunology , Virus Latency
7.
J Clin Virol ; 16(1): 49-54, 2000 Feb.
Article in English | MEDLINE | ID: mdl-10680740

ABSTRACT

BACKGROUND: The seroprevalence of viral childhood infections in Africa has not been thoroughly investigated. The relatively recently discovered human parvovirus B19 (B19) and human herpesvirus 6 (HHV-6) have received particularly little attention. OBJECTIVE: To investigate the seroprevalence of viral childhood infections in different Eritrean populations and to define groups at high risk for infection. STUDY DESIGN: Five population groups in Eritrea have been examined to define the prevalence of specific antibodies to several childhood viruses. The study population of more than 400 persons consisted of children, pregnant women, female sex workers and members of a secluded tribe called Rashaida. RESULTS: All groups showed a high prevalence of antibodies to measles and HHV-6 (> 85%). For rubella, the seroprevalence was very high in all adult groups (93-99%) except the Rashaida group (71%). The mumps prevalence was surprisingly low in the Rashaida group (29%) compared to 46-85% in the other adults. Late encounter of mumps and rubella was also observed among the Rashaidas. The pattern of antibodies to B19 showed a higher seroprevalence in all groups (56-91%) compared to what has been reported from the western world. CONCLUSION: The findings represent what might be expected in an unvaccinated population. The exception was the Rashaidas, which had low seroprevalences and late encounter of mumps and rubella. This is of importance because it makes this tribe vulnerable to these infections, which are associated with complications when acquired in adult age. Also noteworthy is the high frequency of antibodies to HHV-6 and particularly B19 in all groups, indicative of an early encounter of both these viruses.


Subject(s)
Antibodies, Viral/blood , Virus Diseases/epidemiology , Adolescent , Adult , Child , Child, Preschool , Eritrea/epidemiology , Female , Herpesviridae Infections/epidemiology , Herpesviridae Infections/virology , Herpesvirus 6, Human , Humans , Infant , Infant, Newborn , Male , Measles/epidemiology , Measles/virology , Mumps/epidemiology , Mumps/virology , Parvoviridae Infections/epidemiology , Parvoviridae Infections/virology , Parvovirus B19, Human/immunology , Pregnancy , Rubella/epidemiology , Rubella/virology , Seroepidemiologic Studies , Virus Diseases/virology
8.
J Clin Virol ; 14(3): 167-72, 1999 Dec.
Article in English | MEDLINE | ID: mdl-10614853

ABSTRACT

BACKGROUND: Human herpesvirus 8 (HHV-8) is associated with Kaposi's sarcoma. In the US and Europe, HHV-8 is believed to be mainly sexually transmitted, but reports from some African countries suggest non-sexual transmission. OBJECTIVES: To find out more about HHV-8 seroprevalence and transmission in Eastern Africa. STUDY DESIGN: In this study, 411 serum samples from different population groups in Eritrea (children, pregnant women, female sex workers and members of the isolated Rashaida tribe) were examined for HHV-8 antibodies with an immunofluorescence assay detecting antibodies to latent and lytic HHV-8 antigens. RESULTS: Antibodies to HHV-8 latent antigen were found in 0-2% of Eritrean children, 5% of pregnant women, 8% of female sex workers and 26% of Rashaidas, respectively. No correlation was found between detectable HHV-8 antibodies and seropositivity to HIV or herpes simplex 2. CONCLUSIONS: These results suggest that HHV-8 infection is relatively common in Eritrea and that viral transmission occurs predominantly through non-sexual route in this region.


Subject(s)
Antibodies, Viral/blood , Herpesviridae Infections/epidemiology , Herpesvirus 8, Human/immunology , Adolescent , Adult , Aged , Antigens, Viral/immunology , Child , Child, Preschool , Eritrea/epidemiology , Female , Fluorescent Antibody Technique , Herpesviridae Infections/immunology , Humans , Infant , Infant, Newborn , Male , Middle Aged , Pregnancy , Seroepidemiologic Studies , Sex Work
9.
Clin Diagn Lab Immunol ; 6(4): 545-9, 1999 Jul.
Article in English | MEDLINE | ID: mdl-10391860

ABSTRACT

Several studies have suggested an association between human herpesvirus 6 (HHV-6) and multiple sclerosis (MS). We have previously studied intrathecal production of antibody to lymphotropic herpesviruses in MS patients and the presence of human herpesvirus 1 to 7 DNAs in cerebrospinal fluid (CSF). In the present study anti-HHV-6 immunoglobulin M (IgM) in serum and anti-HHV-6 IgG subclasses in serum and CSF were examined and the lymphoproliferative response to HHV-6 was analyzed. The PCR examination was refined by purifying DNA from CSF and retesting the samples for HHV-6 DNA. There were no statistically significant differences between the groups concerning IgM positivity, distribution of IgG subclasses, or lymphoproliferative response to HHV-6. The purification of DNA increased the number of PCR-positive samples from 0 of 71 to 4 of 68. The study does not give additional support to the possibility that HHV-6 is a common cause of MS, but a role for the virus in a subset of patients cannot be excluded.


Subject(s)
Herpesvirus 6, Human/immunology , Multiple Sclerosis/immunology , Adolescent , Adult , Antibody Formation , DNA, Viral/blood , DNA, Viral/cerebrospinal fluid , Female , Herpesvirus 6, Human/genetics , Humans , Immunity, Cellular , Immunoglobulin G/blood , Immunoglobulin M/blood , Lymphocyte Activation , Male , Middle Aged , Multiple Sclerosis/cerebrospinal fluid , Multiple Sclerosis/genetics , Polymerase Chain Reaction
10.
Transpl Int ; 11(5): 336-44, 1998.
Article in English | MEDLINE | ID: mdl-9787409

ABSTRACT

A nested polymerase chain reaction (nPCR) for Epstein-Barr virus (EBV) DNA, RNA in situ hybridization (EBER-ISH), and immunostaining against the ZEBRA EBV protein for diagnosis of EBV hepatitis were performed on 43 liver biopsy specimens obtained from 18 patients in the 1st year after liver transplantation (LTX). The findings were related to liver histology and results of EBV-nPCR on concomitantly obtained serum samples. EBV DNA was detected in 30% and RNA in 34% of the liver biopsy specimens using nPCR and EBER-ISH, respectively, giving a significant correlation between the two methods (P = 0.003). All but one patient had detectable EBV DNA in serum samples obtained within 1 month of the biopsy. More than 90% of the nPCR and EBER-ISH-positive biopsy specimens were obtained 3 months or less post-LTX. There was no significant difference in EBV genome findings in biopsy specimens with or without lymphocytic-immunoblastic infiltrates, either in nPCR (P = 0.73) or in ISH (P = 0.73). Two of three biopsy specimens with these histological changes suggesting a viral genesis were positive in EBV-nPCR but negative in ISH. Histopathological changes in EBV hepatitis may be nonspecific and masked by other complications. The use of EBV-nPCR and EBER-ISH in liver graft biopsy specimens of heavily immunosuppressed patients may give an early indication of EBV-related disease and can be used to guide therapeutic intervention.


Subject(s)
Hepatitis, Viral, Human/diagnosis , Herpesviridae Infections/diagnosis , Herpesvirus 4, Human/genetics , Liver Transplantation/adverse effects , Liver/virology , Tumor Virus Infections/diagnosis , Adolescent , Adult , Biopsy , Child , Child, Preschool , DNA, Viral/analysis , DNA-Binding Proteins/metabolism , Double-Blind Method , Female , Hepatitis, Viral, Human/etiology , Hepatitis, Viral, Human/metabolism , Herpesviridae Infections/etiology , Herpesviridae Infections/metabolism , Humans , Immunoenzyme Techniques , In Situ Hybridization , Infant , Liver/metabolism , Liver/pathology , Male , Middle Aged , Polymerase Chain Reaction , RNA, Viral/analysis , RNA, Viral/metabolism , Trans-Activators/metabolism , Tumor Virus Infections/etiology , Tumor Virus Infections/metabolism , Viral Proteins/metabolism
11.
Acta Neurol Scand ; 95(5): 280-3, 1997 May.
Article in English | MEDLINE | ID: mdl-9188902

ABSTRACT

Several members of the herpesvirus family have been implicated in the pathogenesis of multiple sclerosis (MS). Recently, HHV-6 viral antigen has been demonstrated in association to MS plaques, as well as DNA from human herpesvirus 6 (HHV-6) in cerebrospinal fluid from a few MS patients by polymerase chain reaction (PCR). In the present study, CSF from patients with MS, optic neuritis and other neurological diseases, as well as consecutive CSF and serum samples from MS patients included in a clinical trial with acyclovir, were analysed by nested PCR for the presence of DNA from herpes simplex virus 1 and 2, Epstein-Barr virus, varicella zoster virus, cytomegalovirus, human herpesvirus 6 and 7. No virus DNA was found in any CSF (n = 115) or serum (n = 116) sample. These findings argue against a continuous disseminated herpesvirus infection in MS, but do not rule out a lesion-associated, low-grade herpesvirus infection within the MS brain.


Subject(s)
Herpesvirus 6, Human/isolation & purification , Multiple Sclerosis , Optic Neuritis , Polymerase Chain Reaction , Adolescent , Adult , DNA, Viral , Female , Humans , Male , Middle Aged , Multiple Sclerosis/blood , Multiple Sclerosis/cerebrospinal fluid , Multiple Sclerosis/virology , Optic Neuritis/blood , Optic Neuritis/cerebrospinal fluid , Optic Neuritis/virology , Severity of Illness Index
12.
Transpl Int ; 9(5): 439-45, 1996.
Article in English | MEDLINE | ID: mdl-8875785

ABSTRACT

In immunocompromised HIV-infected and transplanted patients, there is a risk of developing Epstein-Barr virus (EBV)-associated lymphoproliferative disorders (LPD) and lymphomas. EBV has previously been detected by the polymerase chain reaction (PCR) in cerebrospinal fluid from all AIDS patients with EBV-associated cerebral lymphomas. We therefore thought it would be of interest to determine whether transplant patients with extracerebral EBV-associated LPD have detectable EBV genomes in serum. Nested PCR (nPCR) showed that 58% (18/31) of liver transplant (LTX) patients had EBV DNA in 17% (21/125) of serum samples obtained within the first 3 months after LTX. In 39% (7/18) of the patients, the first EBV nPCR-positive sample was found within 2 weeks post-LTX. Basic immunosuppression with cyclosporin A or FK506 did not seem to influence the frequency of detectable EBV genomes in serum. In contrast, positive EBV nPCR correlated to secondary OKT3 treatment for severe acute rejection (P = 0.009). EBV-associated malignant lymphoma developed in three patients 2-6 months post-LTX. In all of them, EBV DNA was amplifiable within 12-14 days after LTX. The EBV antibody titers were not directly related to detectable EBV DNA in serum. We conclude that monitoring of LTX patients receiving increased immunosuppression by nPCR for EBV DNA in serum may help in the early identification of those at risk of developing EBV-associated LPD.


Subject(s)
DNA, Viral/blood , Herpesviridae Infections/blood , Herpesvirus 4, Human/isolation & purification , Immunosuppressive Agents/pharmacology , Liver Transplantation , Tumor Virus Infections/blood , Viremia/blood , Adolescent , Adrenal Cortex Hormones/pharmacology , Adrenal Cortex Hormones/therapeutic use , Adult , Antigens, Viral/blood , Child , Child, Preschool , Cyclosporine/pharmacology , Cyclosporine/therapeutic use , Female , Graft Rejection/drug therapy , Graft Rejection/prevention & control , Herpesviridae Infections/virology , Herpesvirus 4, Human/drug effects , Herpesvirus 4, Human/growth & development , Humans , Immunosuppressive Agents/therapeutic use , Incidence , Infant , Infections/epidemiology , Lymphoma, B-Cell/blood , Lymphoma, B-Cell/etiology , Lymphoma, B-Cell/virology , Male , Middle Aged , Muromonab-CD3/pharmacology , Muromonab-CD3/therapeutic use , Polymerase Chain Reaction , Postoperative Complications/blood , Postoperative Complications/etiology , Postoperative Complications/mortality , Postoperative Complications/virology , Postoperative Period , Survival Rate , Tacrolimus/pharmacology , Tacrolimus/therapeutic use , Tumor Virus Infections/virology , Viral Proteins/blood , Viremia/virology , Virus Activation/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL
...